SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Acquisition of Kinnate Biopharma Inc. by XOMA Corporation
Kinnate Biopharma Inc. (KNTE)
Company Research
Source: GlobeNewswire
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Kinnate Biopharma Inc. (“Kinnate” or the “Company”) (NASDAQ: KNTE) stock purchased prior to February 16, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of Kinnate by XOMA Corporation (“XOMA”). As a result of the merger, Kinnate stockholders will receive $2.3352 per share in cash and additional cash up to $0.2527 per share, plus a contingent value right. This sale of the Company comes after its largest stockholders, OrbiMed and Foresite Capital, kicked off a sales process by publicly announcing their intention to explore a go-private transaction. To learn more about the action and your rights, go to: https://zlk.com/mna2/kinnate-biopharma-inc-lawsuit-submission-form or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by t
Show less
Read more
Impact Snapshot
Event Time:
KNTE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KNTE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KNTE alerts
High impacting Kinnate Biopharma Inc. news events
Weekly update
A roundup of the hottest topics
KNTE
News
- SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates KNTE, DOOR, HMSTGlobeNewswire
- KINNATE BIOPHARMA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kinnate Biopharma Inc. - KNTEBusiness Wire
- SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - EVBG, TAST, ZFOX, KNTEPR Newswire
- XOMA Corp (XOMA) Reports Mixed Financial Results for Q4 and Full Year 2023 [Yahoo! Finance]Yahoo! Finance
- STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - KNTE, INBX, KAMNAccesswire
KNTE
Earnings
- 11/9/23 - Beat
KNTE
Sec Filings
- 4/3/24 - Form S-8
- 4/3/24 - Form S-8
- 4/3/24 - Form S-8
- KNTE's page on the SEC website